A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial

被引：0
|
作者：
Sian Robinson
Aleksander Zincuk
Ulla Lei Larsen
Claus Ekstrøm
Mads Nybo
Bjarne Rasmussen
Palle Toft
机构：
[1] Odense University Hospital (OUH),Department of Anaesthesia and Intensive Care
[2] University of Southern Denmark,Department of Biostatistics
[3] OUH,Department of Clinical Biochemistry and Pharmacology
来源：
Critical Care | / 17卷
关键词：
Enoxaparin; Acute Kidney Injury; Intensive Care Unit Patient; Graduate Compression Stocking; Target Therapeutic Range;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [21] A multicentre, randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients
    Verma, Brij
    Luethi, Nora
    Cioccari, Luca
    Lloyd-Donald, Patryck
    Crisman, Marco
    Eastwood, Glenn
    Orford, Neil
    French, Craig
    Bellomo, Rinaldo
    Martensson, Johan
    CRITICAL CARE AND RESUSCITATION, 2016, 18 (03) : 205 - 212
  • [22] Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT
    Vahtera, Annukka
    Szanto, Timea
    Lassila, Riitta
    Valkonen, Miia
    Sivula, Mirka
    Huhtala, Heini
    Pettila, Ville
    Kuitunen, Anne
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2021, 65 (01) : 109 - 115
  • [23] A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial
    Robinson, Sian
    Zincuk, Aleksander
    Larsen, Ulla Lei
    Ekstrom, Claus
    Toft, Palle
    TRIALS, 2014, 15
  • [24] A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial
    Sian Robinson
    Aleksander Zincuk
    Ulla Lei Larsen
    Claus Ekstrøm
    Palle Toft
    Trials, 15
  • [25] VolumE maNagement Under body composition monitoring in critically ill patientS on CRRT: study protocol for a randomized controlled trial (VENUS trial)
    Oh, Hyung Jung
    An, Jung Nam
    Oh, Sohee
    Rhee, Harin
    Lee, Jung Pyo
    Kim, Dong Ki
    Ryu, Dong-Ryeol
    Kim, Sejoong
    TRIALS, 2018, 19
  • [26] A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury
    Atan, Rafidah
    Peck, Leah
    Prowle, John
    Licari, Elisa
    Eastwood, Glenn M.
    Storr, Markus
    Goehl, Hermann
    Bellomo, Rinaldo
    CRITICAL CARE MEDICINE, 2018, 46 (10) : E988 - E994
  • [27] Patient factors associated with frequent clotting of dialysers during haemodiafiltration in critically ill patients: a post hoc analysis of a randomised controlled study
    Ho, K. M.
    Morgan, D. J.
    ANAESTHESIA AND INTENSIVE CARE, 2014, 42 (01) : 59 - 64
  • [28] Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: A double blind randomized controlled trial
    van der Voort, Peter H. J.
    Boerma, E. Christiaan
    Koopmans, Matty
    Zandberg, Mariet
    de Ruiter, Joke
    Gerritsen, Rik T.
    Egbers, Peter H. M.
    Kingma, W. Peter
    Kuiper, Michael A.
    CRITICAL CARE MEDICINE, 2009, 37 (02) : 533 - 538
  • [29] Randomised controlled trial using daily electrical muscle stimulation (EMS) in critically ill patients to prevent intensive care unit (icu) acquired weakness (ICUAW)
    M Goll
    T Wollersheim
    K Haas
    R Moergeli
    J Malleike
    F Nehls
    K Reiher
    N Carbon
    G Sonomoya
    S Weber-Carstens
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [30] Effect of pneumoperitoneum pressure and the depth of neuromuscular block on renal function in patients with diabetes undergoing laparoscopic pelvic surgery: study protocol for a double-blinded 2 x 2 factorial randomized controlled trial
    Xu, Xiaohan
    Gong, Yahong
    Zhang, Yuelun
    Lang, Jiaxin
    Huang, Yuguang
    TRIALS, 2020, 21 (01)
12345